Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, CryoPort Inc’s stock clocked out at $9.64, down -4.17% from its previous closing price of $10.06. In other words, the price has decreased by -$4.17 from its previous closing price. On the day, 0.59 million shares were traded. CYRX stock price reached its highest trading level at $10.14 during the session, while it also had its lowest trading level at $9.6.
Ratios:
To gain a deeper understanding of CYRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.01 and its Current Ratio is at 15.77. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.44.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 10 ’25 when RAMKUMAR MANDALAM bought 11,570 shares for $9.99 per share.
Hariri Robert J sold 25,000 shares of CYRX for $242,738 on Sep 11 ’25. The Director now owns 51,275 shares after completing the transaction at $9.71 per share. On Sep 11 ’25, another insider, ROBERT HARIRI, who serves as the Director of the company, bought 25,000 shares for $9.71 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 482664256 and an Enterprise Value of 332485248. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.54 while its Price-to-Book (P/B) ratio in mrq is 1.02. Its current Enterprise Value per Revenue stands at 1.364 whereas that against EBITDA is -16.753.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.54, which has changed by 0.25357604 over the last 52 weeks, in comparison to a change of 0.14045572 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $11.44, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is 2.26%, while the 200-Day Moving Average is calculated to be 24.88%.
Shares Statistics:
It appears that CYRX traded 669.98K shares on average per day over the past three months and 536940 shares per day over the past ten days. A total of 50.07M shares are outstanding, with a floating share count of 47.82M. Insiders hold about 4.49% of the company’s shares, while institutions hold 93.95% stake in the company. Shares short for CYRX as of 1764288000 were 3277722 with a Short Ratio of 4.89, compared to 1761868800 on 3138924. Therefore, it implies a Short% of Shares Outstanding of 3277722 and a Short% of Float of 7.8.
Earnings Estimates
The dynamic stock of CryoPort Inc (CYRX) is currently attracting attention from 3.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.02 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.79 and -$0.86 for the fiscal current year, implying an average EPS of -$0.84. EPS for the following year is -$0.58, with 3.0 analysts recommending between -$0.38 and -$0.69.
Revenue Estimates
In. The current quarter, 9 analysts expect revenue to total $42.93M. It ranges from a high estimate of $45.42M to a low estimate of $41.7M. As of. The current estimate, CryoPort Inc’s year-ago sales were $59.53MFor the next quarter, 9 analysts are estimating revenue of $44.54M. There is a high estimate of $45.27M for the next quarter, whereas the lowest estimate is $43M.
A total of 9 analysts have provided revenue estimates for CYRX’s current fiscal year. The highest revenue estimate was $176.15M, while the lowest revenue estimate was $172.4M, resulting in an average revenue estimate of $173.65M. In the same quarter a year ago, actual revenue was $228.38MBased on 9 analysts’ estimates, the company’s revenue will be $189.64M in the next fiscal year. The high estimate is $192.24M and the low estimate is $186.2M.
